While results have been mixed concerning associations between variants in the RXR gene and cancer risk [21]–[24], in vitro animal and human studies have shown that elevated levels of RXRA increases the antiproliferative effects of 1,25(OH)2D3[25], [26]. This evidence concerns the gene RXRA and cancer.